Aurora A Kinase As a Target for Therapy in Rearranged Acute Lymphoblastic Leukemia

Overview

Journal Haematologica

Specialty Hematology

Date 2021 Jul 8

PMID 34233449

Citations 5

Authors

Jessica Leonard

Joelle Sj Wolf

Michelle Degnin

Christopher A Eide

Dorian LaTocha

Kyle Lenz

Beth Wilmot

Charles G Mullighan

Mignon Loh

Stephen P Hunger

Brian J Druker

Marc M Loriaux

Jeffrey W Tyner

Bill H Chang

Affiliations

Soon will be listed here.

Citing Articles

JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results.

Pidala J, Holtan S, Walton K, Kim J, Cao B, Elmariah H Blood. 2024; 144(22):2295-2307.

PMID: 39046783 PMC: 11619790. DOI: 10.1182/blood.2024024789.

Anticancer activity features of imidazole-based ionic liquids and lysosomotropic detergents: in silico and in vitro studies.

Gryniukova A, Borysko P, Myziuk I, Alieksieieva D, Hodyna D, Semenyuta I Mol Divers. 2024; 28(6):3817-3833.

PMID: 38246950 DOI: 10.1007/s11030-023-10779-4.

Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.

Raetz E, Bhojwani D, Devidas M, Gore L, Rabin K, Tasian S Pediatr Blood Cancer. 2023; 70 Suppl 6:e30585.

PMID: 37489549 PMC: 10687839. DOI: 10.1002/pbc.30585.

International Consensus Classification of acute lymphoblastic leukemia/lymphoma.

Duffield A, Mullighan C, Borowitz M Virchows Arch. 2022; 482(1):11-26.

PMID: 36422706 PMC: 10646822. DOI: 10.1007/s00428-022-03448-8.

Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia.

Iacobucci I, Kimura S, Mullighan C J Clin Med. 2021; 10(17).

PMID: 34501239 PMC: 8432032. DOI: 10.3390/jcm10173792.

References

Manfredi M, Ecsedy J, Chakravarty A, Silverman L, Zhang M, Hoar K . Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays. Clin Cancer Res. 2011; 17(24):7614-24. DOI: 10.1158/1078-0432.CCR-11-1536. View

Mosse Y, Fox E, Teachey D, Reid J, Safgren S, Carol H . A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921). Clin Cancer Res. 2019; 25(11):3229-3238. PMC: 6897379. DOI: 10.1158/1078-0432.CCR-18-2675. View

Panagopoulos I, Micci F, Thorsen J, Haugom L, Tierens A, Ulvmoen A . A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13). Cancer Genet. 2012; 205(12):669-72. DOI: 10.1016/j.cancergen.2012.10.004. View

Leonard J, Rowley J, Eide C, Traer E, Hayes-Lattin B, Loriaux M . Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia. Sci Transl Med. 2016; 8(354):354ra114. DOI: 10.1126/scitranslmed.aaf5309. View

Watanabe A, Inukai T, Kagami K, Abe M, Takagi M, Fukushima T . Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy. Cancer Med. 2019; 8(11):5274-5288. PMC: 6718581. DOI: 10.1002/cam4.2356. View

Ma X, Edmonson M, Yergeau D, Muzny D, Hampton O, Rusch M . Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. 2015; 6:6604. PMC: 4377644. DOI: 10.1038/ncomms7604. View

Fischer U, Forster M, Rinaldi A, Risch T, Sungalee S, Warnatz H . Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. Nat Genet. 2015; 47(9):1020-1029. PMC: 4603357. DOI: 10.1038/ng.3362. View

Tyner J, Tognon C, Bottomly D, Wilmot B, Kurtz S, Savage S . Functional genomic landscape of acute myeloid leukaemia. Nature. 2018; 562(7728):526-531. PMC: 6280667. DOI: 10.1038/s41586-018-0623-z. View

Glover J, Loriaux M, Tyner J, Druker B, Chang B . In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011; 59(3):576-9. PMC: 3291800. DOI: 10.1002/pbc.23383. View

10.

Gu Z, Churchman M, Roberts K, Moore I, Zhou X, Nakitandwe J . PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019; 51(2):296-307. PMC: 6525306. DOI: 10.1038/s41588-018-0315-5. View

11.

Mouttet B, Vinti L, Ancliff P, Bodmer N, Brethon B, Cario G . Durable remissions in positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation. Haematologica. 2019; 104(6):e244-e247. PMC: 6545832. DOI: 10.3324/haematol.2018.210104. View

12.

Adams R, Maiato H, Earnshaw W, CARMENA M . Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation. J Cell Biol. 2001; 153(4):865-80. PMC: 2192373. DOI: 10.1083/jcb.153.4.865. View

13.

Zhou H, Kuang J, Zhong L, Kuo W, Gray J, Sahin A . Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998; 20(2):189-93. DOI: 10.1038/2496. View

14.

Frismantas V, Dobay M, Rinaldi A, Tchinda J, Dunn S, Kunz J . Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia. Blood. 2017; 129(11):e26-e37. PMC: 5356455. DOI: 10.1182/blood-2016-09-738070. View